{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:16:36Z","timestamp":1780449396050,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1124\/jpet.118.252155","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T02:35:36Z","timestamp":1544841336000},"page":"326-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine\u2013Induced Status Epilepticus in Rats: Comparison with Allopregnanolone"],"prefix":"10.1016","volume":"368","author":[{"given":"Michael S.","family":"Saporito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Gruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"DiCamillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hinchliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Barker-Haliski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Steven","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.252155_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1113\/jphysiol.2004.066571","article-title":"Neuroactive steroids have multiple actions to potentiate GABAA receptors","volume":"558","author":"Akk","year":"2004","journal-title":"J Physiol"},{"key":"10.1124\/jpet.118.252155_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccc.2014.06.006","article-title":"Neurocritical care: status epilepticus review","volume":"30","author":"Al-Mufti","year":"2014","journal-title":"Crit Care Clin"},{"key":"10.1124\/jpet.118.252155_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.118.252155_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuroscience.2005.07.021","article-title":"Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance","volume":"138","author":"Belelli","year":"2006","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.118.252155_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.118.252155_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/jpet.118.252155_bib7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0706796","article-title":"Mechanism of action of benzodiazepines on GABAA receptors","volume":"148","author":"Campo-Soria","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.252155_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.252155_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.252155_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.118.252155_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"DeLorenzo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.118.252155_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0038-1636052","article-title":"Statisical logic in the monitoring of reactions to therapeutic drugs","volume":"10","author":"Finney","year":"1971","journal-title":"Methods Inf Med"},{"key":"10.1124\/jpet.118.252155_bib15","first-page":"243","article-title":"Effect of covalently bound heparin coating on patency and biocompatibility of long-term indwelling catheters in the rat jugular vein","volume":"52","author":"Foley","year":"2002","journal-title":"Comp Med"},{"key":"10.1124\/jpet.118.252155_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(95)00793-P","article-title":"The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy","volume":"696","author":"Frye","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/jpet.118.252155_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(24)36837-5","article-title":"Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam","volume":"282","author":"Gasior","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.252155_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0028-3908(99)00190-2","article-title":"Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate","volume":"39","author":"Gasior","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.118.252155_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1124\/jpet.118.252155_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/sleep\/32.11.1425","article-title":"The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents","volume":"32","author":"Gruner","year":"2009","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.252155_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/jpet.111.178947","article-title":"Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats","volume":"337","author":"Gruner","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.252155_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.118.252155_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"key":"10.1124\/jpet.118.252155_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.252155_bib25","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1152\/jn.91062.2008","article-title":"A simple quantitative method for analyzing electrographic status epilepticus in rats","volume":"101","author":"Lehmkuhle","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1124\/jpet.118.252155_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2006.10.023","article-title":"The anticonvulsant effects of allopregnanolone against amygdala-kindled seizures in female rats","volume":"411","author":"Lonsdale","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.118.252155_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neulet.2009.12.037","article-title":"Anticonvulsant doses of ganaxolone do not compromise motor performance in immature rats","volume":"469","author":"Mares","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.118.252155_bib28","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/acs.jmedchem.5b00032","article-title":"Neuroactive steroids. 1. Positive allosteric modulators of the (\u03b3-aminobutyric acid)A receptor: structure-activity relationships of heterocyclic substitution at C-21","volume":"58","author":"Martinez Botella","year":"2015","journal-title":"J Med Chem"},{"issue":"Suppl 3","key":"10.1124\/jpet.118.252155_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1528-1167.2010.02622.x","article-title":"Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus","volume":"51","author":"Naylor","year":"2010","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib30","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.118.252155_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/mol.117.108563","article-title":"Rapid throughput analysis of GABAA receptor subtype modulators and blockers using DiSBAC1(3) membrane potential red dye","volume":"92","author":"Nik","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.118.252155_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.118.252155_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fncel.2014.00256","article-title":"Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"8","author":"Pinna","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/jpet.118.252155_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2012.11.005","article-title":"A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus","volume":"231","author":"Pouliot","year":"2013","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.118.252155_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.118.252155_bib36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-3565(24)39026-3","article-title":"Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself","volume":"295","author":"Reddy","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.252155_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","article-title":"Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model","volume":"89","author":"Reddy","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.118.252155_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.118.252155_bib39","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"issue":"Suppl 8","key":"10.1124\/jpet.118.252155_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2007.01336.x","article-title":"Changes in GABAA receptors in status epilepticus","volume":"48","author":"Sperk","year":"2007","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/092986711794927720","article-title":"Comparison of status epilepticus models induced by pilocarpine and nerve agents: a systematic review of the underlying aetiology and adopted therapeutic approaches","volume":"18","author":"Tang","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.118.252155_bib42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus: Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2011.03338.x","article-title":"A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage","volume":"53","author":"White","year":"2012","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.252155_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17512433.2018.1386553","article-title":"A resurging boom in new drugs for epilepsy and brain disorders","volume":"11","author":"Younus","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/jpet.118.252155_bib45","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.eplepsyres.2014.08.015","article-title":"A potential effect of ganaxolone in an animal model of infantile spasms","volume":"108","author":"Yum","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.118.252155_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neuropharm.2009.12.007","article-title":"Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies","volume":"58","author":"Zheng","year":"2010","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"10.1124\/jpet.118.252155_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","volume":"59","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.252155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:56:28Z","timestamp":1739994988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524261188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0022356524261188"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.252155","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine\u2013Induced Status Epilepticus in Rats: Comparison with Allopregnanolone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.252155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}